Future directions and management of liquid biopsy in non-small cell lung cancer
{{output}}
Lung cancer represents the world's most common cause of cancer death. In recent years, we moved from a generic therapeutic strategy to a personalized approach, based on the molecular characterization of the tumor. In this view, liquid biopsy is becoming an imp... ...